Keyphrases
Glioblastoma
100%
Prolactin Receptor
100%
Tumor
60%
Rapamycin
53%
Mammalian Target of Rapamycin (mTOR)
33%
Angiogenesis
26%
MTOR Pathway
26%
JAK-STAT
20%
Brain Tumor
20%
Immune Suppressant
13%
Paracrine
13%
In Cancer
13%
Tumor Metastasis
13%
Glioblastoma Therapy
13%
Tumor Treatment
13%
Receptor Internalization
13%
Cervical Cancer
13%
Drug Use
13%
Established Drugs
13%
Tumor Progression
13%
TSC1
13%
Induced Growth
13%
Clinical Drugs
13%
Antiangiogenic Factors
13%
Epidermal Growth Factor Receptor
13%
Glioblastoma Cells
13%
Overactivity
13%
Growth Inhibition
13%
Recombinant Protein
13%
Growth Signaling
13%
Local Production
13%
Cancer Treatment
13%
Tuberous Sclerosis Complex
13%
Surgical Intervention
6%
Combination Therapy
6%
Intracranial Tumor
6%
Cancer Development
6%
Survival Response
6%
Screening Program
6%
Primary Brain Tumor
6%
During Pregnancy
6%
Cell Growth
6%
Tumor Cell Proliferation
6%
Epidermal Growth Factor Receptor Inhibitors
6%
Receptor Signaling
6%
Human Breast Cancer
6%
GH Family
6%
Angiogenic Inhibitors
6%
Colon Cancer
6%
Vascular Endothelial Growth Factor Receptor (VEGFR)
6%
Neovascularization
6%
Self-sufficiency
6%
Glioblastoma multiforme
6%
HPV16
6%
Human Ovarian Cancer Cell
6%
Smooth muscle Tumor
6%
Cell Differentiation
6%
SOCS1
6%
Intracellular Protein
6%
Breast Cancer Prognosis
6%
Pro-survival
6%
Phosphoinositide 3-kinase (PI3K)
6%
Colorectal Cancer
6%
Clinical Samples
6%
Myometrium
6%
High-risk Human Papillomavirus (HR-HPV)
6%
Angiogenic Factors
6%
Vascularization
6%
Combined Application
6%
New Vessels
6%
Allelic Loss
6%
Endostatin
6%
Tuberous Sclerosis
6%
Tumor Suppressor
6%
Chromosome 10
6%
Primary Glioblastoma
6%
Tensin Homolog
6%
Ink4a
6%
Autocrine Action
6%
Sequential Expression
6%
Tumoral
6%
Clinical Screening
6%
Biallelic
6%
Patient Survival
6%
Cell Signaling Molecules
6%
Malignant Glioma
6%
Cytotoxic Therapy
6%
Uterine Leiomyoma
6%
Suppressor of Cytokine Signaling 3 (SOCS3)
6%
Recurrent Glioblastoma
6%
Overproduction
6%
Mouse Placenta
6%
Tumor Pathogenesis
6%
Oncogenic Signaling
6%
Cell Studies
6%
Median Survival
6%
Lactogenic Hormones
6%
Papillomavirus Infections
6%
Animal Data
6%
Phosphatase
6%
Human Cytomegalovirus Infection
6%
Cytokine Production
6%
SOCS2
6%
Antigrowth
6%
Platelets
6%
Tumor Growth
6%
Salivary Gland Tumor
6%
Genetic mutation
6%
Cancer Hallmarks
6%
New Therapeutics
6%
Cancer Causes
6%
Prolactin
6%
Hepatocellular Cancer
6%
Hormone Action
6%
Viral Infection
6%
Apoptotic Mechanism
6%
Rhabdomyosarcoma
6%
Chemical Exposure
6%
Role in Cancer
6%
Tumor Cells
6%
Prostate Cancer
6%
Human Cancer
6%
Growth Factors
6%
Breast Cancer
6%
Neuroblastoma Tumor
6%
Human Malignancies
6%
High Risk
6%
INIS
glioblastomas
100%
prolactin
100%
receptors
100%
tumors
100%
cancer
73%
humans
47%
growth
39%
drugs
34%
proteins
30%
blocking
26%
pathogenesis
17%
angiogenesis
17%
brain
17%
levels
17%
signals
13%
patients
13%
production
13%
breasts
13%
hormones
13%
growth factors
13%
connections
8%
slowdown
8%
metastases
8%
therapy
8%
losses
8%
genetics
8%
mutations
8%
proliferation
8%
tumor cells
8%
Medicine and Dentistry
Prolactin Receptor
100%
Glioblastoma
100%
Neoplasm
45%
Mammalian Target of Rapamycin
40%
Malignant Neoplasm
36%
Rapamycin
36%
Tumor Progression
18%
Angiogenesis
18%
Receptor
18%
Brain Tumor
18%
Breast Cancer
13%
Metastatic Carcinoma
9%
Proliferin
9%
Cervical Cancer
9%
Antiangiogenic
9%
Prolactin
9%
Immunosuppressive Drug
9%
Recombinant Protein
9%
Angiogenic Factor
9%
Cancer Therapy
9%
Cancer Treatment
9%
Target Cell
9%
Internalization
9%